Pfizer Share Price

Pfizer Share Price

NSE: PFIZER
|
Pharmaceuticals

₹ 4,053.50

+₹181.10 (4.68%)
1D
Last updated 13 Oct, 2026, 15:55 IST

Pfizer Share Price Today

As of 13 Oct 2026, Pfizer share price is ₹4,053.50. The stock opened at ₹3,872.40, compared to its previous close of ₹3,872.40. During today's trading session, Pfizer share price moved in the range of ₹3,784.40 to ₹4,123.90, with an average price of ₹3,954.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,731.00 and a high of ₹5,578.50. On the performance front, Pfizer share price has declined by 16.45% over the last six months and is down 26.69% on a year-on-year basis.

₹3,784.40
4.68% up today
₹4,123.90
1D LOW
1D HIGH

Pfizer Returns Calculator

Volume
67,758
Average traded price
₹3,971.82
Last traded time
03:55:58 13 Oct
Last traded quantity
1
Circuit
L
H
₹3,098.00
₹4,646.80
52-week
L
H
₹3,731.00
₹5,578.50
Mkt Cap Cr
17,735.48
P/E
24.12
P/B
4.22
ROA
33.25%
ROE
19.78%
ROCE
27.27%
Quick Ratio
5.31
EV/EBITDA
13.59
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Pfizer has not beaten FD return of 7%
Step 3 of 5
Valuation
Fairly Valued
Pfizer appears to be fairly valued compared to its peers
Step 1 of 5
Earnings
Very Poor
Pfizer revenue, operating profits and net profits have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Pfizer

Pfizer Share Price
ISIN
INE182A01018
Sector Market Cap
₹ 17,735.48 Cr

Pfizer Limited (Pfizer) is an India-based multinational pharmaceutical company focusing on therapy in four business categories, namely, Vaccines, Hospitals, Internal Medicine, and Inflammation and Immunology. Pfizer’s Vaccines Division focuses on Prevenar 13, a Pneumococcal Conjugate Vaccine approved for administering to individuals of all ages against pneumococcal disease, an infection caused by streptococcus pneumoniae bacteria. Internal Medicine portfolio includes approximately 17 specialties and seven therapy areas, including respiratory, multivitamin and multimineral, gastrointestinal, pain, neuroscience, cardiovascular and women’s healthcare. Pfizer Hospital Business Unit focuses on providing advanced anti-infectives to institutions such as hospitals and nursing homes. Inflammation and Immunology focuses on discovering and developing novel therapeutics for chronic autoimmune diseases. Its brands include Prevenar13, CorexDX, Dolonex, Enbrel, Becosules and Folvite, among others.

Pfizer Financial Highlights

  • Revenue: Pfizer reported revenue of ₹867.69 crore in FY09 vs ₹982.61 crore in FY08. It showed a decrease of 11.70% on a yearly basis.
  • Operating Profit: Pfizer reported an operating profit of ₹210.01 crore in FY09 vs ₹419.13 crore in FY08. It showed a decrease of 49.89% on a year-on-year basis.
  • Net Profit: Pfizer reported a net profit of ₹137.12 crore in FY09 vs ₹299.58 crore in FY08. It showed a decrease of 54.23% on a yearly basis.

Pfizer Quarterly Result Highlights

  • Pfizer reported revenue of ₹698.01 crore in Jun 2026, compared with ₹669.95 crore in Mar 2026, representing an increase of 4.19% on a quarter-on-quarter (QoQ) basis.
  • Pfizer reported an operating profit of ₹276.68 crore in Jun 2026, compared with ₹268.82 crore in Mar 2026, representing an increase of 2.92% on a quarter-on-quarter (QoQ) basis.
  • Pfizer reported a profit of ₹204.47 crore in Jun 2026, compared with ₹199.82 crore in Mar 2026, reflecting an increase of 2.33% on a QoQ basis.
  • The earnings per share (EPS) of Pfizer stood at ₹157.92 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
63.92%
FII
1.65%
Other DII
5.12%
Retail and other
16.63%
Mutual funds
12.68%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20252.60%
Dec 20252.71%
Mar 20262.81%
Jun 20261.65%
1 day
+4.68%
1 week
+5.23%
1 month
-0.17%
1 year
-26.69%
3 years
+1.95%
5 years
-26.83%
Day
Open / Close
Change %
12 Oct 26
₹3,809.10 / ₹3,872.40
+1.69%
09 Oct 26
₹3,750.00 / ₹3,808.20
+1.55%
08 Oct 26
₹3,815.10 / ₹3,750.00
-1.71%
07 Oct 26
₹3,870.00 / ₹3,815.10
-0.96%
Show more

Pfizer Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsNov 2006Nov 2007Nov 2008Nov 2009
Revenue769.81,019.76982.61867.69
Operating profit162.64451.34419.13210.01
Net profit106.33340299.58137.12

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,519.65₹2,281.35₹2,193.17₹2,424.76
Other Income₹187.95₹172.25₹180.51₹101.05
Total Revenue₹2,707.60₹2,453.60₹2,373.68₹2,525.81
Total Expenses₹1,682.77₹1,610.32₹1,635.56₹1,734.80
Profit Before Tax₹975.67₹1,016.09₹746.07₹824.01
Tax₹253.24₹248.49₹194.74₹200.08
Profit After Tax₹722.43₹767.60₹551.33₹623.93
EPS - Basic₹157.92₹167.79₹119.22₹136.38
EPS - Diluted₹157.92₹167.79₹120.51₹136.38

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹975.67₹1,016.09₹746.07₹824.01
Income before WC changes₹912.85₹770.52₹656.75₹692.75
Change in Assets-₹12.27₹7.23-₹89.91₹85.03
Change in Liabilities₹52.46₹38.22-₹156.18-₹119.52
Change in WC₹40.19₹45.45-₹246.09-₹34.49
Cash flow from Operations₹967.57₹659.75₹256.84₹355.68
Cash flow from Investing-₹561.67-₹71.34₹53.70-₹36.05
Cash flow from Financing-₹798.31-₹205.34-₹235.14-₹345.79
Total Cash Flow-₹392.41₹383.07₹75.40-₹26.16
Cash (Start of the year)₹495.07₹112.00₹36.60₹62.76
Cash (End of the year)₹102.66₹495.07₹112.00₹36.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,118.66₹1,398.26₹1,490.97₹1,475.64
Current Assets₹3,803.22₹3,512.85₹2,737.81₹2,525.09
Total Assets₹4,921.88₹4,911.11₹4,228.78₹4,000.73
Current Liabilities₹627.48₹569.51₹546.56₹657.35
Net Current Asset₹3,175.74₹2,943.34₹2,191.25₹1,867.74
Non-Current Liabilities₹91.50₹124.19₹86.68₹136.08
Equity Capital₹4,202.90₹4,217.41₹3,595.54₹3,207.30
Total Equity & Liabilities₹4,921.88₹4,911.11₹4,228.78₹4,000.73
* All values are in INR Crore
Qty
Bid
159
4053.5
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 159
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
5
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
32.57
Neutral
ATR (14)
76
Neutral
STOCH(9,6)
55.02
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
72.95
Bearish
UO(9)
49.13
Neutral
ROC(12)
-3.8
Bearish
WillR(14)
-57.79
Neutral
Period
Simple value
Exponential vaue
5D
3819.58
3835.33
10D
3855.52
3870.09
20D
3939.79
3987.29
50D
4429.62
4258.62
100D
4503.9
4434.61
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Pfizer Share Price
Pfizer
Pharmaceuticals
Add Stock
Add Another

Pfizer Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.